Navigation Links
Pair of MicroRNA Molecules Controls Major Oncogene in Most Common Leukemia

Researchers at Ohio State University have discovered that two microRNA (miRNA) molecules help control the oncogene responsible for a dangerous form of B-cell chronic// lymphocytic leukemia (B-CLL), the most common human leukemia in the world.

Their findings, published in the December 15 issue of Cancer Research, demonstrate that miRNAs are emerging as powerful regulators of gene expression in cancer development, and could offer new targets for drug treatment, the investigators say.

In this case, high levels of two miRNAs known as miR-29 and miR-181 seem to suppress expression of the TCL1 oncogene that drives the most aggressive forms of the leukemia, said the study’s lead author, Yuri Pekarsky, Ph.D., assistant professor in the Department of Molecular Virology, Immunology and Medical Genetics at Ohio State University’s Comprehensive Cancer Center.

“We have found a direct inverse association between expression of miR-29 and miR-181 and that of the TCL1 oncogene,” he said. “It works in both directions. High expression of these miRNAs correlates with low expression of TCL1, in the indolent form of cancer that is less likely to progress. A low level of miR-29 and miR-181 is associated with a much more aggressive cancer.”

Drugs that boost production of these two natural TCL1 inhibitors might work as a future treatment for B-cell chronic lymphocytic leukemia, he said. These molecules could also be combined with 12 other miRNAs known to be associated with B-CLL to provide a test that may help determine prognosis and treatment, he said.

Researchers at Ohio State have been leaders in characterizing the role of miRNAs in cancer development. These small molecules are single-stranded RNA molecules that can act either as tumor suppressors or oncogenes. They can block transcription of genes by stopping them from producing messenger RNA or can inhibit translation of the genes by blocking production of proteins f
'"/>




Page: 1 2

Related medicine news :

1. MicroRNA provides new insight into birth defects
2. Role Of MicroRNAs In Angiogenesis Researched
3. MicroRNAs Can Be Tumor Suppressors
4. Sensor Can Detect "Unhealthy" Molecules In Breath
5. Protein Molecules in blood predict preeclampsia development
6. Leukemia Drug Turns Mini-Molecules Up, Cancer Genes Down
7. Penn Scientists Engineer Small Molecules to Probe Proteins Deep Inside Cell Membrane
8. Scientists Discover Hormone That Controls Hunger
9. Brain behind the Brawn: Vital Molecule in the Brain Controls Appetite
10. Stronger Quadricep Controls Knee Osteoarthritis
11. Molecular ‘On/Off Switch’ Controls Immune Defenses Against Viruss

Post Your Comments:
(Date:11/30/2009)...aunched a series of clinical trials in order to as...his approach involves the application of personali...s from the patient him or herself and designed to ...nd frequent malignant tumours. The new therapy is ...th the standard, first-line treatment involving su...
(Date:11/30/2009)...do knees, internal injuries, study finds, , ...re a middle-age weekend warrior who likes to hit t...ew study suggests that high levels of physical act...could lead to osteoarthritis. , The study found...ho showed no symptoms and had a healthy weight. Th...
(Date:11/30/2009)...giving catalog to help families make charitable gi... 30 In spite of the eco...y season willing to support charities in two ways,...wn wallets to support charities and nearly 40 perc...instead of buying them a gift, according to a new ...
(Date:11/30/2009)...ewswire-FirstCall/ -- Stryker Corporation (NYSE: ...acquire privately held Ascent Healthcare Solutions...emanufacturing of medical devices in the U.S. ,...acquire Ascent Healthcare Solutions for $525 milli...itioned on the expiration or termination of all ap...
(Date:11/30/2009)...k up , , MONDAY, Nov. 30 (HealthDay News...e U.S. Congress differ in a number of ways but ach...mber of uninsured Americans. , Legislation appr...month would expand coverage to 96 percent of Ameri... to expand coverage to 94 percent of Americans. ,...
Breaking Medicine News(10 mins):Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 2Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 3Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 4Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 5Health News:Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines 6Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 2Health News:Lots of Exercise in Midlife May Lead to Osteoarthritis 3Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 2Health News:American Red Cross Survey Finds 62 Percent of Americans Plan to Donate More Than $25 to Charity This Holiday Season in Spite of Economic Downturn 3Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 2Health News:Stryker Announces Definitive Agreement To Acquire Ascent Healthcare Solutions 3Health News:Health Reform: What's in It for You? 2Health News:Health Reform: What's in It for You? 3
...enefits of Frameless Delivery and Fractionation De... Preservation , , SUNNYVALE, Calif., May 5 Accur... in the field of radiosurgery, announced today tha...ion of Neurological Surgeons (AANS) Annual Meeting...
...nline and Phone Based Survey Encourages Nurses to ...areers , , , PORTLAND, Ore., May 5 Vigilan, the...brates National Nurse Week May 6-12, 2009 by liste...ementia care. Vigilan is offering an online and p...
...ONDON, May 5 Initiatives taken by European govern...ion surveillance systems have aimed at improving e...r, the lack of basic level automation is proving t...ts across Europe to install infection surveillance...
...ADISON HEIGHTS, Mich., May 5 InfuSystem Holdings... the leading provider of ambulatory infusion pumps... financial results and provided a business update ...e first quarter of 2009, despite a nationwide shor...
...irst Diagnostic Test for Identifying E. coli, K. p... Blood Cultures , , PNA FISH Provides Critical Re... to Help Clinicians Improve Care and Outcomes for ...0(k) clearance for EK/ P. aeruginosa PNA FISH(R) ...
... , , REDWOOD CITY, Calif., May 5 Ingenuity Syste...for life science researchers, today announced a mu...plans to expand the utilization of IPA in its rese... researchers plan to leverage the powerful analysi...
Other Medicine News:Health News:Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications 2Health News:Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications 3Health News:Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications 4Health News:Presentations at Leading Neurosurgery Meeting Highlight Benefits of CyberKnife Radiosurgery for the Treatment of CNS Indications 5Health News:Vigilan Honors National Nurse Week in Assisted Living, Independent Living and Dementia Care 2Health News:Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe 2Health News:Frost & Sullivan: Rising Public Awareness Promoting Acceptance of Infection Surveillance Systems Across Europe 3Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 2Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 3Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 4Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 5Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 6Health News:InfuSystem Holdings Reports $9.2 Million of Revenue and 45% Increase in Adjusted EBITDA for the First Quarter of 2009 7Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 2Health News:AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R) 3Health News:Ingenuity Systems Announces Multi-Year Deal With AstraZeneca 2Health News:Ingenuity Systems Announces Multi-Year Deal With AstraZeneca 3
(Date:11/30/2009)... , NEW YORK, Nov. 30 Report...port is available in its catalogue: ,, Surgica.../www.reportlinker.com/p0164299/Surgical-Incision-C...ion closures market holds enormous significance, d...rformed each year. Surgical disciplines such as ca...
(Date:11/30/2009)..., KING OF PRUSSIA, Pa., Nov. 30 ... completion of a Phase I study of CPSI-2364, its o...uction of TNF-alpha and other pro-inflammatory cyt...se escalation study in healthy volunteers confirm ...sting. ,, All 30 enrolled subjects completed ...
(Date:11/30/2009)..., CHICAGO, Nov. 30 MedPro Imagi...asound solutions, will showcase leading ultrasound...iq I and Siemens X300 Premium Edition during the c...rth America (RSNA) conference, being held in Chica... MedPro Imaging markets ultrasound products and se...
Breaking Medicine Technology:Reportlinker Adds Surgical Incision Closures - Global Trends 2Reportlinker Adds Surgical Incision Closures - Global Trends 3Reportlinker Adds Surgical Incision Closures - Global Trends 4Reportlinker Adds Surgical Incision Closures - Global Trends 5Reportlinker Adds Surgical Incision Closures - Global Trends 6Reportlinker Adds Surgical Incision Closures - Global Trends 7Cytokine PharmaSciences Completes Phase I Study of Oral Anti-Inflammatory Agent, CPSI-2364 2MedPro Imaging to Showcase Leading New and Refurbished Ultrasound Solutions at RSNA 2Relators Attorneys Comment On AtriCure DOJ Proposed Settlement 5996 1Relators Attorneys Comment On AtriCure DOJ Proposed Settlement 5996 2USGS science picks 10641 1USGS science picks 10641 2USGS science picks 10641 3USGS science picks 10641 4USGS science picks 10641 5USGS science picks 10641 6USGS science picks 10641 7TV bombards children with commercials for high fat and high sugar foods 10639 1TV bombards children with commercials for high fat and high sugar foods 10639 2TV bombards children with commercials for high fat and high sugar foods 10639 3
...YORK, May 16 Pulmo BioTech Inc. (OTC,Bulletin Boa...ogy and,purpose of its Phase I Human Trials with i...diagnosis of Pulmonary Embolism and Pulmonary,Hype...lmo BioTech subsidiary,PulmoScience Inc., and the ... PulmoBind for Molecular Imaging of the Pulmonary ...
...GEWATER, N.J., May 16 Data from three studies,eva...emoglobin (Hb) levels,and the rate of blood transf...ions on reimbursement for erythropoiesis-stimulati...n,s blood supply, will be presented at the,America...ng later this,month. The meeting will take place i...
Other Medicine Technology:Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 2New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 3New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 4New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 5New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nation's Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting 6
Revo Rotator Cuff Repair System
BioROC EZ Fasteners and Instrumentation
...a fully absorbable soft tissue anchor designed spe...s dynamic engagement into cancellous bone, its bro...de significant resistance to pullout in soft bone....ction provides the benefits of fixation strength c...
...ade; Ti Quick-T Fixation System is a single-step t...r secondary tissue fixation. This through tendon t...e Anchor combined with our pretied knot technology...e of PEEK-OPTIMA® LT3 polymer from Invibio. Th...
Medicine Products: